home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

United States Approval of First Totally Implanted Permanent Artificial Heart

  September, 7 2006 17:40
your information resource in human molecular genetics
The U.S. Food and Drug Administration approved the first totally implanted artificial heart for patients with advanced heart failure in both of the heart�s pumping chambers. The device is intended for patients who are not eligible for a heart transplant and whose life expectancy without the device is only a month. Heart failure is a serious condition in which the heart is unable to pump enough blood throughout the body. About 5 million people in the United States have heart failure and it contributes to or causes about 300,000 deaths every year.

The approval of the totally implanted artificial heart is a significant milestone as there are few options for heart failure patients with the most severe form of the disease and who are in critical need.

NHLBI Communications Office

Message posted by: Rashmi Nemade

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.